These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 10583624)

  • 21. Discordance of pediatric morphea treatment by pediatric dermatologists.
    Tollefson MM; Chiu YE; Brandling-Bennett HA; Pope E
    Pediatr Dermatol; 2018 Jan; 35(1):47-54. PubMed ID: 29165838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Pediatric Dermatologist's View of Pediatric Vitiligo.
    Weingarten M; Schwartz M; Heath C; Silverberg NB
    J Drugs Dermatol; 2024 Feb; 23(2):e77-e78. PubMed ID: 38306136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The development of guidelines for the treatment of vitiligo. Clinical Epidemiology Unit of the Istituto Dermopatico dell'Immacolata-Istituto di Recovero e Cura a Carattere Scientifico (IDI-IRCCS) and the Archives of Dermatology.
    Njoo MD; Westerhof W; Bos JD; Bossuyt PM
    Arch Dermatol; 1999 Dec; 135(12):1514-21. PubMed ID: 10606057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Narrow-band UVB therapy in psoriasis vulgaris: good practice guideline and recommendations of the French Society of Photodermatology].
    Beani JC; Jeanmougin M
    Ann Dermatol Venereol; 2010 Jan; 137(1):21-31. PubMed ID: 20110064
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of psoralen plus ultraviolet A irradiation on cultured epidermal cells in vitro and patients with vitiligo in vivo.
    Wu CS; Lan CC; Wang LF; Chen GS; Wu CS; Yu HS
    Br J Dermatol; 2007 Jan; 156(1):122-9. PubMed ID: 17199578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral and topical L-phenylalanine, clobetasol propionate, and UVA/sunlight--a new study for the treatment of vitiligo.
    Camacho F; Mazuecos J
    J Drugs Dermatol; 2002 Sep; 1(2):127-31. PubMed ID: 12847735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Home ultraviolet B phototherapy for psoriasis: discrepancy between literature, guidelines, general opinions and actual use. Results of a literature review, a web search, and a questionnaire among dermatologists.
    Koek MB; Buskens E; Bruijnzeel-Koomen CA; Sigurdsson V
    Br J Dermatol; 2006 Apr; 154(4):701-11. PubMed ID: 16536814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current state of vitiligo therapy--evidence-based analysis of the literature.
    Forschner T; Buchholtz S; Stockfleth E
    J Dtsch Dermatol Ges; 2007 Jun; 5(6):467-75. PubMed ID: 17537039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
    Yones SS; Palmer RA; Garibaldinos TM; Hawk JL
    Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vitiligo treatment in childhood: a state of the art review.
    Tamesis ME; Morelli JG
    Pediatr Dermatol; 2010; 27(5):437-45. PubMed ID: 20553403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of vitiligo with narrow-band UVB and topical gel containing catalase and superoxide dismutase.
    Kostović K; Pastar Z; Pasić A; Ceović R
    Acta Dermatovenerol Croat; 2007; 15(1):10-4. PubMed ID: 17433173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of systemic PUVA and NB-UVB in the treatment of vitiligo: an open prospective study.
    Bhatnagar A; Kanwar AJ; Parsad D; De D
    J Eur Acad Dermatol Venereol; 2007 May; 21(5):638-42. PubMed ID: 17447977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From basic research to the bedside: efficacy of topical treatment with pseudocatalase PC-KUS in 71 children with vitiligo.
    Schallreuter KU; Krüger C; Würfel BA; Panske A; Wood JM
    Int J Dermatol; 2008 Jul; 47(7):743-53. PubMed ID: 18613887
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and Safety Comparison of Basic Fibroblast Growth Factor-Related Decapeptide 0.1% Solution (bFGFrP) Plus Oral PUVA Combination Therapy with Oral PUVA Monotherapy in the Treatment of Vitiligo.
    Nayak CS; Kura MM; Banerjee G; Patil SP; Deshpande A; Sekar S; Sharma A; Pathak R; Sarma P
    J Cutan Aesthet Surg; 2023; 16(1):28-33. PubMed ID: 37383981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical treatment and combination approaches for vitiligo: new insights, new developments.
    Hossani-Madani AR; Halder RM
    G Ital Dermatol Venereol; 2010 Feb; 145(1):57-78. PubMed ID: 20197746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical study of repigmentation patterns with different treatment modalities and their correlation with speed and stability of repigmentation in 352 vitiliginous patches.
    Parsad D; Pandhi R; Dogra S; Kumar B
    J Am Acad Dermatol; 2004 Jan; 50(1):63-7. PubMed ID: 14699367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of vitiligo in children.Symposium.
    Grimes PE; Kelly AP; Cline DJ; Nordlund JJ; Jareatt MT; Rogers M; Treadwell PA; Burgdorf WH; Kenney JA
    Pediatr Dermatol; 1986 Dec; 3(6):498-510. PubMed ID: 3562364
    [No Abstract]   [Full Text] [Related]  

  • 38. Management of vitiligo patients and attitude of dermatologists towards vitiligo.
    Ongenae K; Van Geel N; De Schepper S; Vander Haeghen Y; Naeyaert JM
    Eur J Dermatol; 2004; 14(3):177-81. PubMed ID: 15246945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study.
    Ermis O; Alpsoy E; Cetin L; Yilmaz E
    Br J Dermatol; 2001 Sep; 145(3):472-5. PubMed ID: 11531839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A review of monochromatic excimer light in vitiligo.
    Park KK; Liao W; Murase JE
    Br J Dermatol; 2012 Sep; 167(3):468-78. PubMed ID: 22524428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.